News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vitrolife (VITR.ST) Release: Interim Report January-March 2014: Strengthened Operating Margin


4/23/2014 8:55:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

First quarter in brief:

· Sales growth was 12 percent in local currency. Sales amounted to SEK 119 (105) million, corresponding to an increase of 14 percent in SEK. · Operating income (EBIT) amounted to SEK 30 (17) million, corresponding to an operating margin of 25 (16) percent.
Operating income included a recovered additional purchase price of SEK 2 million regarding the acquisition of Cryo Management Ltd. Adjusted for this, the operating margin amounted to 23 (16) percent.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Vitrolife
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES